All In MedTech

FDA Clearance Tracker · P180032-S023

Cerene® Cryotherapy Device

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jul 8, 2026 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P180032-S023
Device name
Cerene® Cryotherapy Device
Applicant location
Emeryville, CA
Received
Jun 12, 2026
Decided
Jul 8, 2026
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P180032

Device type

Device class
Class III

Every decision under product code MNB

FDA's approval statement

As written in FDA's record.

The recommended decision for this file is Approve PMA GMP without inspection. This recommendation is based on transferring a low-risk labeling activity to a manufacturing site (and sponsor) previously approved under the PMA.

Source documents

Other decisions for Channel Medsystems, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.